Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial

Detalles Bibliográficos
Autores principales: Gyselinck, Iwein, Liesenborghs, Laurens, Landeloos, Ewout, Belmans, Ann, Verbeke, Geert, Verhamme, Peter, Vos, Robin, Janssens, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933907/
https://www.ncbi.nlm.nih.gov/pubmed/33673831
http://dx.doi.org/10.1186/s13063-021-05153-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933907/
https://www.ncbi.nlm.nih.gov/pubmed/33673831
http://dx.doi.org/10.1186/s13063-021-05153-4

Ejemplares similares